2020
DOI: 10.3389/fimmu.2020.00910
|View full text |Cite|
|
Sign up to set email alerts
|

Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy

Abstract: Tuberculosis (TB) is a leading cause of death worldwide following infection with Mycobacterium tuberculosis (Mtb), with 1.5 million deaths from this disease reported in 2018. Once the bacilli are inhaled, alveolar and interstitial macrophages become infected with Mtb and differentiate into lipid-laden foamy macrophages leading to lung inflammation. Thus, the presence of lipid-laden foamy macrophages is the hallmark of TB granuloma; these Mtb-infected foamy macrophages are the major niche for Mtb survival. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
71
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 69 publications
(71 citation statements)
references
References 93 publications
(128 reference statements)
0
71
0
Order By: Relevance
“…In the caseating debris of human TB granulomas, there is an enrichment of cholesterol, cholesteryl esters, and triacylglycerides (TAGs), with the latter being the main components of the large lipid droplets commonly found in foamy macrophages, another important niche for Mtb [ 36 , 37 ]. Phagosome-containing Mtb can be found tightly associated with lipid droplets [ 38 ] and Mtb can translocate to these droplets where it utilizes lipids as a carbon source for survival [ 39 , 40 ]. Interestingly, elevated levels of TAGs are found during rapid disease development caused by modern Mtb Beijing strains compared to ancient Mtb Beijing strains [ 41 ], highlighting the importance of lipid metabolism in TB pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…In the caseating debris of human TB granulomas, there is an enrichment of cholesterol, cholesteryl esters, and triacylglycerides (TAGs), with the latter being the main components of the large lipid droplets commonly found in foamy macrophages, another important niche for Mtb [ 36 , 37 ]. Phagosome-containing Mtb can be found tightly associated with lipid droplets [ 38 ] and Mtb can translocate to these droplets where it utilizes lipids as a carbon source for survival [ 39 , 40 ]. Interestingly, elevated levels of TAGs are found during rapid disease development caused by modern Mtb Beijing strains compared to ancient Mtb Beijing strains [ 41 ], highlighting the importance of lipid metabolism in TB pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Increasing evidence has indicated that EVs are used by parasites to orchestrate bene cial changes in the host environment and to ensure successful infection or activate the innate immune response to control infection [25,26,27]. EVs and their cargo can participate in cell-to-cell communication via various functional biomolecules, including proteins, bioactive lipids, and RNA, which can alter recipient cell functions [28,29,30]; therefore, our previous study also selected NEVs as vaccine controls.…”
Section: Discussionmentioning
confidence: 99%
“…Macrophages infected with Mtb increase lipid metabolism, which results in lipid droplet (LD) formation and further differentiation into “foamy” macrophages within granulomas ( Hunter et al, 2007 ; Peyron et al, 2008 ; Shim et al, 2020 ). Mtb and other bacteria are believed to specifically induce LD formation as a pathogenic strategy for use as a carbon source to promote intracellular growth ( Saka and Valdivia, 2012 ; Nolan et al, 2017 ).…”
Section: Overview Of Metabolic Interactions Between Host Immune Cellsmentioning
confidence: 99%
“…Since host cells and Mtb are extensively dependent on lipid and carbohydrate metabolic pathways, these metabolic pathways can be used as treatment targets ( Shim et al, 2020 ). Formation of host foamy macrophages can persist during bacterial infection and contribute to the cavitation and release of infectious bacilli in patients with active disease ( Pandey and Sassetti, 2008 ; Griffin et al, 2012 ).…”
Section: Using Metabolic Pathways To Develop Novel Therapeutic Stratementioning
confidence: 99%